Your browser doesn't support javascript.
loading
Differences in time to patient access to innovative cancer medicines in six European countries.
Vancoppenolle, Julie M; Franzen, Nora; Koole, Simone N; Retèl, Valesca P; van Harten, Wim H.
Affiliation
  • Vancoppenolle JM; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Franzen N; Department Health Technology and Services Research Technical Medical Centre, University of Twente, Enschede, The Netherlands.
  • Koole SN; The European Fair Pricing Network, Amsterdam, The Netherlands.
  • Retèl VP; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • van Harten WH; Department Health Technology and Services Research Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Int J Cancer ; 154(5): 886-894, 2024 Mar 01.
Article in En | MEDLINE | ID: mdl-37864395
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Country/Region as subject: Europa Language: En Journal: Int J Cancer Year: 2024 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Country/Region as subject: Europa Language: En Journal: Int J Cancer Year: 2024 Type: Article Affiliation country: Netherlands